Komjathy Andrew has filed 7 insider transactions across 1 company since February 2024.
Most recent transaction: a disposition of 45 shares of Astria Therapeutics, Inc. ($ATXS) on January 23, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 23, 2026 | Astria Therapeutics, Inc. | $ATXS | Komjathy Andrew | Chief Commercial Officer | D | Common Stock | 45 | $0.00 | 0.0000 | 58,005,928 | 100.00% | 0.00% |
| Jan. 23, 2026 | Astria Therapeutics, Inc. | $ATXS | Komjathy Andrew | Chief Commercial Officer | D | Stock Option (Right to Buy) | 55000 | $0.00 | 0.0000 | 58,005,928 | 100.00% | 0.09% |
| Jan. 23, 2026 | Astria Therapeutics, Inc. | $ATXS | Komjathy Andrew | Chief Commercial Officer | D | Stock Option (Right to Buy) | 225000 | $0.00 | 0.0000 | 58,005,928 | 100.00% | 0.39% |
| Jan. 23, 2026 | Astria Therapeutics, Inc. | $ATXS | Komjathy Andrew | Chief Commercial Officer | D | Common Stock | 10 | $0.00 | 0.0000 | 58,005,928 | 100.00% | 0.00% |
| Jan. 23, 2026 | Astria Therapeutics, Inc. | $ATXS | Komjathy Andrew | Chief Commercial Officer | D | Common Stock | 45 | $0.00 | 0.0000 | 58,005,928 | 100.00% | 0.00% |
| March 21, 2025 | Astria Therapeutics, Inc. | $ATXS | Komjathy Andrew | Chief Commercial Officer | A | Stock Option (Right to Buy) | 225000 | $0.00 | 225,000.0000 | 56,161,249 | 9999.99% | 0.40% |
| Feb. 8, 2024 | Astria Therapeutics, Inc. | $ATXS | Komjathy Andrew | Chief Commercial Officer | A | Stock Option (Right to Buy) | 175000 | $0.00 | 175,000.0000 | 30,123,316 | 9999.99% | 0.58% |